⌘K

Login Start Free

Home/Filings/4/0001209191-13-040761

4//SEC Filing

HALOZYME THERAPEUTICS INC 4

Accession 0001209191-13-040761

$HALOCIK 0001159036operating

View on SEC.gov Company Profile

Filed

Aug 13, 8:00 PM ET

Accepted

Aug 14, 6:27 PM ET

Size

6.5 KB

Accession

0001209191-13-040761

Insider Transaction Report

Form 4

Period: 2013-08-12

HALOZYME THERAPEUTICS INCHALO

Frost Gregory Ian

DirectorVP and Chief Scientific Off.

Transactions

Exercise/Conversion
Common Stock
2013-08-12$2.05/sh+20,000$41,000→ 3,591,380 total
Exercise/Conversion
Option to Purchase Common Stock
2013-08-12$2.05/sh−20,000$41,000→ 40,000 total
Exercise: $2.05From: 2008-05-01Exp: 2014-10-13→ Common Stock (20,000 underlying)

Documents

1 file

4
c584188_4x0.xmlPrimary
MAIN DOCUMENT DESCRIPTION

Issuer

HALOZYME THERAPEUTICS INC

CIK 0001159036

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001159036

Filing Metadata

Form type: 4
Filed: Aug 13, 8:00 PM ET
Accepted: Aug 14, 6:27 PM ET
Size: 6.5 KB

View on SEC.gov